nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexamethasone—NR0B1—Tretinoin—peripheral nervous system neoplasm	0.153	0.233	CbGbCtD
Dexamethasone—ABCB1—peripheral nervous system neoplasm	0.129	1	CbGaD
Dexamethasone—CYP4A11—Tretinoin—peripheral nervous system neoplasm	0.0733	0.112	CbGbCtD
Dexamethasone—NR0B1—Vincristine—peripheral nervous system neoplasm	0.0701	0.107	CbGbCtD
Dexamethasone—NOS2—Doxorubicin—peripheral nervous system neoplasm	0.0366	0.0559	CbGbCtD
Dexamethasone—CYP4A11—Cisplatin—peripheral nervous system neoplasm	0.0314	0.0479	CbGbCtD
Dexamethasone—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0156	0.0239	CbGbCtD
Dexamethasone—ABCG2—Topotecan—peripheral nervous system neoplasm	0.0156	0.0238	CbGbCtD
Dexamethasone—ABCB11—Vincristine—peripheral nervous system neoplasm	0.014	0.0213	CbGbCtD
Dexamethasone—CYP1A1—Tretinoin—peripheral nervous system neoplasm	0.0134	0.0204	CbGbCtD
Dexamethasone—CYP1A1—Dacarbazine—peripheral nervous system neoplasm	0.0115	0.0175	CbGbCtD
Dexamethasone—ABCG2—Dactinomycin—peripheral nervous system neoplasm	0.0108	0.0165	CbGbCtD
Dexamethasone—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0163	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0107	0.0163	CbGbCtD
Dexamethasone—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.0102	0.0155	CbGbCtD
Dexamethasone—CYP2E1—Dacarbazine—peripheral nervous system neoplasm	0.00888	0.0135	CbGbCtD
Dexamethasone—CYP1B1—Doxorubicin—peripheral nervous system neoplasm	0.00874	0.0133	CbGbCtD
Dexamethasone—ABCB11—Doxorubicin—peripheral nervous system neoplasm	0.00874	0.0133	CbGbCtD
Dexamethasone—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.00802	0.0122	CbGbCtD
Dexamethasone—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.00771	0.0118	CbGbCtD
Dexamethasone—ABCC2—Vincristine—peripheral nervous system neoplasm	0.00735	0.0112	CbGbCtD
Dexamethasone—ABCC2—Cisplatin—peripheral nervous system neoplasm	0.00686	0.0105	CbGbCtD
Dexamethasone—PTGS2—Cisplatin—peripheral nervous system neoplasm	0.00678	0.0103	CbGbCtD
Dexamethasone—ABCC2—Etoposide—peripheral nervous system neoplasm	0.00674	0.0103	CbGbCtD
Dexamethasone—PTGS2—Etoposide—peripheral nervous system neoplasm	0.00666	0.0102	CbGbCtD
Dexamethasone—ABCG2—Vincristine—peripheral nervous system neoplasm	0.00665	0.0101	CbGbCtD
Dexamethasone—ABCG2—Cisplatin—peripheral nervous system neoplasm	0.0062	0.00946	CbGbCtD
Dexamethasone—ABCG2—Etoposide—peripheral nervous system neoplasm	0.00609	0.0093	CbGbCtD
Dexamethasone—ABCB1—Topotecan—peripheral nervous system neoplasm	0.00562	0.00857	CbGbCtD
Dexamethasone—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.00562	0.00857	CbGbCtD
Dexamethasone—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.00538	0.00821	CbGbCtD
Dexamethasone—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.00491	0.00749	CbGbCtD
Dexamethasone—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.00491	0.00749	CbGbCtD
Dexamethasone—ABCC2—Doxorubicin—peripheral nervous system neoplasm	0.0046	0.00701	CbGbCtD
Dexamethasone—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.00436	0.00666	CbGbCtD
Dexamethasone—CYP2E1—Etoposide—peripheral nervous system neoplasm	0.00434	0.00663	CbGbCtD
Dexamethasone—ABCG2—Doxorubicin—peripheral nervous system neoplasm	0.00416	0.00634	CbGbCtD
Dexamethasone—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.00389	0.00594	CbGbCtD
Dexamethasone—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.00368	0.00562	CbGbCtD
Dexamethasone—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00338	0.00515	CbGbCtD
Dexamethasone—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.00336	0.00514	CbGbCtD
Dexamethasone—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00325	0.00495	CbGbCtD
Dexamethasone—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00313	0.00477	CbGbCtD
Dexamethasone—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00292	0.00446	CbGbCtD
Dexamethasone—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0024	0.00366	CbGbCtD
Dexamethasone—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0023	0.00352	CbGbCtD
Dexamethasone—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00224	0.00341	CbGbCtD
Dexamethasone—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0022	0.00335	CbGbCtD
Dexamethasone—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0015	0.00229	CbGbCtD
Dexamethasone—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00144	0.00219	CbGbCtD
Dexamethasone—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00141	0.00215	CbGbCtD
Dexamethasone—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00132	0.00201	CbGbCtD
Dexamethasone—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.000898	0.00137	CbGbCtD
Dexamethasone—Triamcinolone—BCHE—peripheral nervous system neoplasm	0.000262	0.303	CrCbGaD
Dexamethasone—Fluticasone furoate—ABCB1—peripheral nervous system neoplasm	0.000152	0.177	CrCbGaD
Dexamethasone—Methylprednisolone—ABCB1—peripheral nervous system neoplasm	0.000122	0.141	CrCbGaD
Dexamethasone—Prednisone—ABCB1—peripheral nervous system neoplasm	9.3e-05	0.108	CrCbGaD
Dexamethasone—Prednisolone—ABCB1—peripheral nervous system neoplasm	8.57e-05	0.0992	CrCbGaD
Dexamethasone—Betamethasone—ABCB1—peripheral nervous system neoplasm	8.4e-05	0.0972	CrCbGaD
Dexamethasone—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	7.11e-05	0.000437	CcSEcCtD
Dexamethasone—Increased appetite—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000436	CcSEcCtD
Dexamethasone—Migraine—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000436	CcSEcCtD
Dexamethasone—Affect lability—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000436	CcSEcCtD
Dexamethasone—Dizziness—Tretinoin—peripheral nervous system neoplasm	7.07e-05	0.000434	CcSEcCtD
Dexamethasone—Dizziness—Isotretinoin—peripheral nervous system neoplasm	7.07e-05	0.000434	CcSEcCtD
Dexamethasone—Insomnia—Vincristine—peripheral nervous system neoplasm	7.06e-05	0.000434	CcSEcCtD
Dexamethasone—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	7.04e-05	0.000432	CcSEcCtD
Dexamethasone—Paraesthesia—Vincristine—peripheral nervous system neoplasm	7.01e-05	0.00043	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	7e-05	0.000429	CcSEcCtD
Dexamethasone—Malaise—Etoposide—peripheral nervous system neoplasm	6.99e-05	0.000429	CcSEcCtD
Dexamethasone—Fatigue—Alitretinoin—peripheral nervous system neoplasm	6.99e-05	0.000429	CcSEcCtD
Dexamethasone—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	6.98e-05	0.000429	CcSEcCtD
Dexamethasone—Vertigo—Etoposide—peripheral nervous system neoplasm	6.96e-05	0.000427	CcSEcCtD
Dexamethasone—Pain—Alitretinoin—peripheral nervous system neoplasm	6.93e-05	0.000425	CcSEcCtD
Dexamethasone—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	6.91e-05	0.000424	CcSEcCtD
Dexamethasone—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	6.91e-05	0.000424	CcSEcCtD
Dexamethasone—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	6.9e-05	0.000424	CcSEcCtD
Dexamethasone—Oedema—Cisplatin—peripheral nervous system neoplasm	6.9e-05	0.000424	CcSEcCtD
Dexamethasone—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000423	CcSEcCtD
Dexamethasone—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	6.86e-05	0.000421	CcSEcCtD
Dexamethasone—Infection—Cisplatin—peripheral nervous system neoplasm	6.86e-05	0.000421	CcSEcCtD
Dexamethasone—Vomiting—Topotecan—peripheral nervous system neoplasm	6.85e-05	0.000421	CcSEcCtD
Dexamethasone—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.00042	CcSEcCtD
Dexamethasone—Mood swings—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.00042	CcSEcCtD
Dexamethasone—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	6.81e-05	0.000418	CcSEcCtD
Dexamethasone—Lethargy—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.000418	CcSEcCtD
Dexamethasone—Vomiting—Tretinoin—peripheral nervous system neoplasm	6.8e-05	0.000417	CcSEcCtD
Dexamethasone—Vomiting—Isotretinoin—peripheral nervous system neoplasm	6.8e-05	0.000417	CcSEcCtD
Dexamethasone—Rash—Topotecan—peripheral nervous system neoplasm	6.8e-05	0.000417	CcSEcCtD
Dexamethasone—Dermatitis—Topotecan—peripheral nervous system neoplasm	6.79e-05	0.000417	CcSEcCtD
Dexamethasone—Decreased appetite—Vincristine—peripheral nervous system neoplasm	6.79e-05	0.000417	CcSEcCtD
Dexamethasone—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	6.77e-05	0.000416	CcSEcCtD
Dexamethasone—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	6.76e-05	0.000415	CcSEcCtD
Dexamethasone—Headache—Topotecan—peripheral nervous system neoplasm	6.75e-05	0.000415	CcSEcCtD
Dexamethasone—Rash—Tretinoin—peripheral nervous system neoplasm	6.74e-05	0.000414	CcSEcCtD
Dexamethasone—Rash—Isotretinoin—peripheral nervous system neoplasm	6.74e-05	0.000414	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	6.74e-05	0.000414	CcSEcCtD
Dexamethasone—Tachycardia—Cisplatin—peripheral nervous system neoplasm	6.74e-05	0.000414	CcSEcCtD
Dexamethasone—Dermatitis—Tretinoin—peripheral nervous system neoplasm	6.74e-05	0.000413	CcSEcCtD
Dexamethasone—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	6.74e-05	0.000413	CcSEcCtD
Dexamethasone—Fatigue—Vincristine—peripheral nervous system neoplasm	6.73e-05	0.000413	CcSEcCtD
Dexamethasone—Convulsion—Etoposide—peripheral nervous system neoplasm	6.72e-05	0.000412	CcSEcCtD
Dexamethasone—Vomiting—Melphalan—peripheral nervous system neoplasm	6.71e-05	0.000412	CcSEcCtD
Dexamethasone—Headache—Isotretinoin—peripheral nervous system neoplasm	6.7e-05	0.000411	CcSEcCtD
Dexamethasone—Headache—Tretinoin—peripheral nervous system neoplasm	6.7e-05	0.000411	CcSEcCtD
Dexamethasone—Hypertension—Etoposide—peripheral nervous system neoplasm	6.69e-05	0.000411	CcSEcCtD
Dexamethasone—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	6.68e-05	0.00041	CcSEcCtD
Dexamethasone—Pain—Vincristine—peripheral nervous system neoplasm	6.68e-05	0.00041	CcSEcCtD
Dexamethasone—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.00041	CcSEcCtD
Dexamethasone—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	6.68e-05	0.00041	CcSEcCtD
Dexamethasone—Rash—Melphalan—peripheral nervous system neoplasm	6.65e-05	0.000409	CcSEcCtD
Dexamethasone—Dermatitis—Melphalan—peripheral nervous system neoplasm	6.65e-05	0.000408	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	6.63e-05	0.000407	CcSEcCtD
Dexamethasone—Dry skin—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000406	CcSEcCtD
Dexamethasone—Anorexia—Cisplatin—peripheral nervous system neoplasm	6.58e-05	0.000404	CcSEcCtD
Dexamethasone—Affect lability—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000403	CcSEcCtD
Dexamethasone—Migraine—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000403	CcSEcCtD
Dexamethasone—Hypokalaemia—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000403	CcSEcCtD
Dexamethasone—Hydrocortisone—ABCB1—peripheral nervous system neoplasm	6.55e-05	0.0759	CrCbGaD
Dexamethasone—Discomfort—Etoposide—peripheral nervous system neoplasm	6.52e-05	0.0004	CcSEcCtD
Dexamethasone—Hypotension—Cisplatin—peripheral nervous system neoplasm	6.45e-05	0.000396	CcSEcCtD
Dexamethasone—Urticaria—Alitretinoin—peripheral nervous system neoplasm	6.44e-05	0.000395	CcSEcCtD
Dexamethasone—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	6.41e-05	0.000393	CcSEcCtD
Dexamethasone—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	6.41e-05	0.000393	CcSEcCtD
Dexamethasone—Nausea—Topotecan—peripheral nervous system neoplasm	6.4e-05	0.000393	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	6.39e-05	0.000392	CcSEcCtD
Dexamethasone—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	6.36e-05	0.000391	CcSEcCtD
Dexamethasone—Nausea—Tretinoin—peripheral nervous system neoplasm	6.35e-05	0.00039	CcSEcCtD
Dexamethasone—Nausea—Isotretinoin—peripheral nervous system neoplasm	6.35e-05	0.00039	CcSEcCtD
Dexamethasone—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	6.35e-05	0.00039	CcSEcCtD
Dexamethasone—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	6.33e-05	0.000388	CcSEcCtD
Dexamethasone—Mood swings—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000388	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	6.29e-05	0.000386	CcSEcCtD
Dexamethasone—Infection—Etoposide—peripheral nervous system neoplasm	6.28e-05	0.000386	CcSEcCtD
Dexamethasone—Asthenia—Dactinomycin—peripheral nervous system neoplasm	6.27e-05	0.000385	CcSEcCtD
Dexamethasone—Nausea—Melphalan—peripheral nervous system neoplasm	6.27e-05	0.000385	CcSEcCtD
Dexamethasone—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	6.2e-05	0.000381	CcSEcCtD
Dexamethasone—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	6.19e-05	0.00038	CcSEcCtD
Dexamethasone—Tachycardia—Etoposide—peripheral nervous system neoplasm	6.17e-05	0.000379	CcSEcCtD
Dexamethasone—Abdominal pain—Vincristine—peripheral nervous system neoplasm	6.17e-05	0.000379	CcSEcCtD
Dexamethasone—Body temperature increased—Vincristine—peripheral nervous system neoplasm	6.17e-05	0.000379	CcSEcCtD
Dexamethasone—Dry skin—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.000376	CcSEcCtD
Dexamethasone—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	6.12e-05	0.000375	CcSEcCtD
Dexamethasone—Hypokalaemia—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000373	CcSEcCtD
Dexamethasone—Anorexia—Etoposide—peripheral nervous system neoplasm	6.03e-05	0.00037	CcSEcCtD
Dexamethasone—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	6e-05	0.000368	CcSEcCtD
Dexamethasone—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	5.98e-05	0.000367	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	5.96e-05	0.000366	CcSEcCtD
Dexamethasone—Hypotension—Etoposide—peripheral nervous system neoplasm	5.91e-05	0.000363	CcSEcCtD
Dexamethasone—Pain—Cisplatin—peripheral nervous system neoplasm	5.9e-05	0.000362	CcSEcCtD
Dexamethasone—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	5.89e-05	0.000361	CcSEcCtD
Dexamethasone—Asthenia—Alitretinoin—peripheral nervous system neoplasm	5.81e-05	0.000357	CcSEcCtD
Dexamethasone—Pruritus—Alitretinoin—peripheral nervous system neoplasm	5.73e-05	0.000352	CcSEcCtD
Dexamethasone—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	5.69e-05	0.000349	CcSEcCtD
Dexamethasone—Paraesthesia—Etoposide—peripheral nervous system neoplasm	5.68e-05	0.000349	CcSEcCtD
Dexamethasone—Weight increased—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000348	CcSEcCtD
Dexamethasone—Weight decreased—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.000346	CcSEcCtD
Dexamethasone—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000345	CcSEcCtD
Dexamethasone—Asthenia—Vincristine—peripheral nervous system neoplasm	5.6e-05	0.000344	CcSEcCtD
Dexamethasone—Vomiting—Dactinomycin—peripheral nervous system neoplasm	5.56e-05	0.000341	CcSEcCtD
Dexamethasone—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	5.54e-05	0.00034	CcSEcCtD
Dexamethasone—Rash—Dactinomycin—peripheral nervous system neoplasm	5.51e-05	0.000338	CcSEcCtD
Dexamethasone—Decreased appetite—Etoposide—peripheral nervous system neoplasm	5.5e-05	0.000338	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	5.46e-05	0.000335	CcSEcCtD
Dexamethasone—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	5.46e-05	0.000335	CcSEcCtD
Dexamethasone—Fatigue—Etoposide—peripheral nervous system neoplasm	5.45e-05	0.000335	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	5.45e-05	0.000335	CcSEcCtD
Dexamethasone—Pain—Etoposide—peripheral nervous system neoplasm	5.41e-05	0.000332	CcSEcCtD
Dexamethasone—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	5.4e-05	0.000332	CcSEcCtD
Dexamethasone—Dizziness—Alitretinoin—peripheral nervous system neoplasm	5.36e-05	0.000329	CcSEcCtD
Dexamethasone—Diarrhoea—Vincristine—peripheral nervous system neoplasm	5.34e-05	0.000328	CcSEcCtD
Dexamethasone—Weight increased—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000322	CcSEcCtD
Dexamethasone—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.00032	CcSEcCtD
Dexamethasone—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	5.21e-05	0.00032	CcSEcCtD
Dexamethasone—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000319	CcSEcCtD
Dexamethasone—Nausea—Dactinomycin—peripheral nervous system neoplasm	5.19e-05	0.000319	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	5.17e-05	0.000318	CcSEcCtD
Dexamethasone—Dizziness—Vincristine—peripheral nervous system neoplasm	5.16e-05	0.000317	CcSEcCtD
Dexamethasone—Vomiting—Alitretinoin—peripheral nervous system neoplasm	5.15e-05	0.000316	CcSEcCtD
Dexamethasone—Rash—Alitretinoin—peripheral nervous system neoplasm	5.11e-05	0.000314	CcSEcCtD
Dexamethasone—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	5.1e-05	0.000313	CcSEcCtD
Dexamethasone—Bradycardia—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000312	CcSEcCtD
Dexamethasone—Headache—Alitretinoin—peripheral nervous system neoplasm	5.08e-05	0.000312	CcSEcCtD
Dexamethasone—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	5.04e-05	0.00031	CcSEcCtD
Dexamethasone—Urticaria—Etoposide—peripheral nervous system neoplasm	5.03e-05	0.000308	CcSEcCtD
Dexamethasone—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	5.02e-05	0.000308	CcSEcCtD
Dexamethasone—Abdominal pain—Etoposide—peripheral nervous system neoplasm	5e-05	0.000307	CcSEcCtD
Dexamethasone—Body temperature increased—Etoposide—peripheral nervous system neoplasm	5e-05	0.000307	CcSEcCtD
Dexamethasone—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	5e-05	0.000307	CcSEcCtD
Dexamethasone—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	4.99e-05	0.000306	CcSEcCtD
Dexamethasone—Vomiting—Vincristine—peripheral nervous system neoplasm	4.97e-05	0.000305	CcSEcCtD
Dexamethasone—Asthenia—Cisplatin—peripheral nervous system neoplasm	4.95e-05	0.000304	CcSEcCtD
Dexamethasone—Rash—Vincristine—peripheral nervous system neoplasm	4.92e-05	0.000302	CcSEcCtD
Dexamethasone—Dermatitis—Vincristine—peripheral nervous system neoplasm	4.92e-05	0.000302	CcSEcCtD
Dexamethasone—Headache—Vincristine—peripheral nervous system neoplasm	4.89e-05	0.0003	CcSEcCtD
Dexamethasone—Nausea—Alitretinoin—peripheral nervous system neoplasm	4.81e-05	0.000295	CcSEcCtD
Dexamethasone—Visual impairment—Epirubicin—peripheral nervous system neoplasm	4.81e-05	0.000295	CcSEcCtD
Dexamethasone—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	4.72e-05	0.00029	CcSEcCtD
Dexamethasone—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000289	CcSEcCtD
Dexamethasone—Eye disorder—Epirubicin—peripheral nervous system neoplasm	4.66e-05	0.000286	CcSEcCtD
Dexamethasone—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	4.64e-05	0.000285	CcSEcCtD
Dexamethasone—Nausea—Vincristine—peripheral nervous system neoplasm	4.64e-05	0.000285	CcSEcCtD
Dexamethasone—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	4.62e-05	0.000283	CcSEcCtD
Dexamethasone—Asthenia—Etoposide—peripheral nervous system neoplasm	4.54e-05	0.000279	CcSEcCtD
Dexamethasone—Angiopathy—Epirubicin—peripheral nervous system neoplasm	4.53e-05	0.000278	CcSEcCtD
Dexamethasone—Pruritus—Etoposide—peripheral nervous system neoplasm	4.48e-05	0.000275	CcSEcCtD
Dexamethasone—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000274	CcSEcCtD
Dexamethasone—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	4.45e-05	0.000273	CcSEcCtD
Dexamethasone—Alopecia—Epirubicin—peripheral nervous system neoplasm	4.41e-05	0.000271	CcSEcCtD
Dexamethasone—Vomiting—Cisplatin—peripheral nervous system neoplasm	4.39e-05	0.000269	CcSEcCtD
Dexamethasone—Rash—Cisplatin—peripheral nervous system neoplasm	4.35e-05	0.000267	CcSEcCtD
Dexamethasone—Dermatitis—Cisplatin—peripheral nervous system neoplasm	4.35e-05	0.000267	CcSEcCtD
Dexamethasone—Erythema—Epirubicin—peripheral nervous system neoplasm	4.34e-05	0.000267	CcSEcCtD
Dexamethasone—Diarrhoea—Etoposide—peripheral nervous system neoplasm	4.33e-05	0.000266	CcSEcCtD
Dexamethasone—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	4.32e-05	0.000265	CcSEcCtD
Dexamethasone—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000257	CcSEcCtD
Dexamethasone—Dizziness—Etoposide—peripheral nervous system neoplasm	4.18e-05	0.000257	CcSEcCtD
Dexamethasone—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000253	CcSEcCtD
Dexamethasone—Nausea—Cisplatin—peripheral nervous system neoplasm	4.1e-05	0.000252	CcSEcCtD
Dexamethasone—Alopecia—Doxorubicin—peripheral nervous system neoplasm	4.08e-05	0.000251	CcSEcCtD
Dexamethasone—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	4.03e-05	0.000247	CcSEcCtD
Dexamethasone—Vomiting—Etoposide—peripheral nervous system neoplasm	4.02e-05	0.000247	CcSEcCtD
Dexamethasone—Erythema—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	0.000247	CcSEcCtD
Dexamethasone—Rash—Etoposide—peripheral nervous system neoplasm	3.99e-05	0.000245	CcSEcCtD
Dexamethasone—Dermatitis—Etoposide—peripheral nervous system neoplasm	3.98e-05	0.000245	CcSEcCtD
Dexamethasone—Headache—Etoposide—peripheral nervous system neoplasm	3.96e-05	0.000243	CcSEcCtD
Dexamethasone—Malaise—Epirubicin—peripheral nervous system neoplasm	3.92e-05	0.000241	CcSEcCtD
Dexamethasone—Vertigo—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.00024	CcSEcCtD
Dexamethasone—Syncope—Epirubicin—peripheral nervous system neoplasm	3.9e-05	0.000239	CcSEcCtD
Dexamethasone—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	3.82e-05	0.000234	CcSEcCtD
Dexamethasone—Convulsion—Epirubicin—peripheral nervous system neoplasm	3.76e-05	0.000231	CcSEcCtD
Dexamethasone—Nausea—Etoposide—peripheral nervous system neoplasm	3.76e-05	0.000231	CcSEcCtD
Dexamethasone—Hypertension—Epirubicin—peripheral nervous system neoplasm	3.75e-05	0.00023	CcSEcCtD
Dexamethasone—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	3.73e-05	0.000229	CcSEcCtD
Dexamethasone—Myalgia—Epirubicin—peripheral nervous system neoplasm	3.7e-05	0.000227	CcSEcCtD
Dexamethasone—Anxiety—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000226	CcSEcCtD
Dexamethasone—Discomfort—Epirubicin—peripheral nervous system neoplasm	3.65e-05	0.000224	CcSEcCtD
Dexamethasone—Malaise—Doxorubicin—peripheral nervous system neoplasm	3.63e-05	0.000223	CcSEcCtD
Dexamethasone—Vertigo—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000222	CcSEcCtD
Dexamethasone—Syncope—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	0.000221	CcSEcCtD
Dexamethasone—Oedema—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000218	CcSEcCtD
Dexamethasone—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	3.55e-05	0.000218	CcSEcCtD
Dexamethasone—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	3.53e-05	0.000217	CcSEcCtD
Dexamethasone—Infection—Epirubicin—peripheral nervous system neoplasm	3.52e-05	0.000216	CcSEcCtD
Dexamethasone—Shock—Epirubicin—peripheral nervous system neoplasm	3.49e-05	0.000214	CcSEcCtD
Dexamethasone—Convulsion—Doxorubicin—peripheral nervous system neoplasm	3.48e-05	0.000214	CcSEcCtD
Dexamethasone—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000213	CcSEcCtD
Dexamethasone—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	3.47e-05	0.000213	CcSEcCtD
Dexamethasone—Hypertension—Doxorubicin—peripheral nervous system neoplasm	3.47e-05	0.000213	CcSEcCtD
Dexamethasone—Tachycardia—Epirubicin—peripheral nervous system neoplasm	3.46e-05	0.000212	CcSEcCtD
Dexamethasone—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	3.43e-05	0.00021	CcSEcCtD
Dexamethasone—Myalgia—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.00021	CcSEcCtD
Dexamethasone—Anxiety—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000209	CcSEcCtD
Dexamethasone—Discomfort—Doxorubicin—peripheral nervous system neoplasm	3.38e-05	0.000208	CcSEcCtD
Dexamethasone—Anorexia—Epirubicin—peripheral nervous system neoplasm	3.38e-05	0.000207	CcSEcCtD
Dexamethasone—Hypotension—Epirubicin—peripheral nervous system neoplasm	3.31e-05	0.000203	CcSEcCtD
Dexamethasone—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000201	CcSEcCtD
Dexamethasone—Oedema—Doxorubicin—peripheral nervous system neoplasm	3.28e-05	0.000201	CcSEcCtD
Dexamethasone—Infection—Doxorubicin—peripheral nervous system neoplasm	3.26e-05	0.0002	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	3.23e-05	0.000198	CcSEcCtD
Dexamethasone—Shock—Doxorubicin—peripheral nervous system neoplasm	3.23e-05	0.000198	CcSEcCtD
Dexamethasone—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000198	CcSEcCtD
Dexamethasone—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	3.21e-05	0.000197	CcSEcCtD
Dexamethasone—Insomnia—Epirubicin—peripheral nervous system neoplasm	3.21e-05	0.000197	CcSEcCtD
Dexamethasone—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	3.2e-05	0.000197	CcSEcCtD
Dexamethasone—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	3.18e-05	0.000195	CcSEcCtD
Dexamethasone—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	3.17e-05	0.000195	CcSEcCtD
Dexamethasone—Anorexia—Doxorubicin—peripheral nervous system neoplasm	3.13e-05	0.000192	CcSEcCtD
Dexamethasone—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	3.12e-05	0.000192	CcSEcCtD
Dexamethasone—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	3.08e-05	0.000189	CcSEcCtD
Dexamethasone—Hypotension—Doxorubicin—peripheral nervous system neoplasm	3.07e-05	0.000188	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000188	CcSEcCtD
Dexamethasone—Fatigue—Epirubicin—peripheral nervous system neoplasm	3.06e-05	0.000188	CcSEcCtD
Dexamethasone—Pain—Epirubicin—peripheral nervous system neoplasm	3.03e-05	0.000186	CcSEcCtD
Dexamethasone—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	2.99e-05	0.000183	CcSEcCtD
Dexamethasone—Insomnia—Doxorubicin—peripheral nervous system neoplasm	2.97e-05	0.000182	CcSEcCtD
Dexamethasone—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	2.95e-05	0.000181	CcSEcCtD
Dexamethasone—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	2.92e-05	0.000179	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	2.9e-05	0.000178	CcSEcCtD
Dexamethasone—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	2.89e-05	0.000177	CcSEcCtD
Dexamethasone—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	2.85e-05	0.000175	CcSEcCtD
Dexamethasone—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000174	CcSEcCtD
Dexamethasone—Fatigue—Doxorubicin—peripheral nervous system neoplasm	2.83e-05	0.000174	CcSEcCtD
Dexamethasone—Urticaria—Epirubicin—peripheral nervous system neoplasm	2.82e-05	0.000173	CcSEcCtD
Dexamethasone—Pain—Doxorubicin—peripheral nervous system neoplasm	2.81e-05	0.000172	CcSEcCtD
Dexamethasone—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000172	CcSEcCtD
Dexamethasone—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	2.8e-05	0.000172	CcSEcCtD
Dexamethasone—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	2.7e-05	0.000166	CcSEcCtD
Dexamethasone—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	2.68e-05	0.000165	CcSEcCtD
Dexamethasone—Urticaria—Doxorubicin—peripheral nervous system neoplasm	2.61e-05	0.00016	CcSEcCtD
Dexamethasone—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000159	CcSEcCtD
Dexamethasone—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	2.59e-05	0.000159	CcSEcCtD
Dexamethasone—Asthenia—Epirubicin—peripheral nervous system neoplasm	2.54e-05	0.000156	CcSEcCtD
Dexamethasone—Pruritus—Epirubicin—peripheral nervous system neoplasm	2.51e-05	0.000154	CcSEcCtD
Dexamethasone—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	2.43e-05	0.000149	CcSEcCtD
Dexamethasone—Asthenia—Doxorubicin—peripheral nervous system neoplasm	2.35e-05	0.000145	CcSEcCtD
Dexamethasone—Dizziness—Epirubicin—peripheral nervous system neoplasm	2.34e-05	0.000144	CcSEcCtD
Dexamethasone—Pruritus—Doxorubicin—peripheral nervous system neoplasm	2.32e-05	0.000142	CcSEcCtD
Dexamethasone—Vomiting—Epirubicin—peripheral nervous system neoplasm	2.25e-05	0.000138	CcSEcCtD
Dexamethasone—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	2.24e-05	0.000138	CcSEcCtD
Dexamethasone—Rash—Epirubicin—peripheral nervous system neoplasm	2.24e-05	0.000137	CcSEcCtD
Dexamethasone—Dermatitis—Epirubicin—peripheral nervous system neoplasm	2.23e-05	0.000137	CcSEcCtD
Dexamethasone—Headache—Epirubicin—peripheral nervous system neoplasm	2.22e-05	0.000136	CcSEcCtD
Dexamethasone—Dizziness—Doxorubicin—peripheral nervous system neoplasm	2.17e-05	0.000133	CcSEcCtD
Dexamethasone—Nausea—Epirubicin—peripheral nervous system neoplasm	2.11e-05	0.000129	CcSEcCtD
Dexamethasone—Vomiting—Doxorubicin—peripheral nervous system neoplasm	2.09e-05	0.000128	CcSEcCtD
Dexamethasone—Rash—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000127	CcSEcCtD
Dexamethasone—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	2.07e-05	0.000127	CcSEcCtD
Dexamethasone—Headache—Doxorubicin—peripheral nervous system neoplasm	2.06e-05	0.000126	CcSEcCtD
Dexamethasone—Nausea—Doxorubicin—peripheral nervous system neoplasm	1.95e-05	0.00012	CcSEcCtD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.79e-05	0.000342	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	1.78e-05	0.000341	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.000339	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—TH—peripheral nervous system neoplasm	1.77e-05	0.000338	CbGpPWpGaD
Dexamethasone—ABCG2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.75e-05	0.000335	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—TH—peripheral nervous system neoplasm	1.75e-05	0.000334	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.71e-05	0.000327	CbGpPWpGaD
Dexamethasone—CYP19A1—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.67e-05	0.00032	CbGpPWpGaD
Dexamethasone—NOS2—Disease—PTPN11—peripheral nervous system neoplasm	1.67e-05	0.000319	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.66e-05	0.000317	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—BCHE—peripheral nervous system neoplasm	1.65e-05	0.000315	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.63e-05	0.000312	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ENO2—peripheral nervous system neoplasm	1.63e-05	0.000312	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.63e-05	0.000311	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GNS—peripheral nervous system neoplasm	1.62e-05	0.000311	CbGpPWpGaD
Dexamethasone—PTGS2—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	1.61e-05	0.000308	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.59e-05	0.000305	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—TP53—peripheral nervous system neoplasm	1.58e-05	0.000303	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.58e-05	0.000301	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.57e-05	0.000301	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.57e-05	0.000301	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—MYC—peripheral nervous system neoplasm	1.57e-05	0.0003	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	1.56e-05	0.000298	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—NME1—peripheral nervous system neoplasm	1.56e-05	0.000298	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—TH—peripheral nervous system neoplasm	1.55e-05	0.000296	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.55e-05	0.000296	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.55e-05	0.000296	CbGpPWpGaD
Dexamethasone—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.54e-05	0.000294	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GNS—peripheral nervous system neoplasm	1.53e-05	0.000292	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.52e-05	0.000292	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.52e-05	0.00029	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—HRAS—peripheral nervous system neoplasm	1.51e-05	0.00029	CbGpPWpGaD
Dexamethasone—PGR—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	1.51e-05	0.00029	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.5e-05	0.000287	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—COX2—peripheral nervous system neoplasm	1.5e-05	0.000287	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	1.5e-05	0.000286	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.49e-05	0.000284	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.47e-05	0.000282	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—NME1—peripheral nervous system neoplasm	1.46e-05	0.00028	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.46e-05	0.00028	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.45e-05	0.000278	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.44e-05	0.000276	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GNS—peripheral nervous system neoplasm	1.44e-05	0.000276	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	1.44e-05	0.000275	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—GNAS—peripheral nervous system neoplasm	1.43e-05	0.000273	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.42e-05	0.000271	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.41e-05	0.000271	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—COX2—peripheral nervous system neoplasm	1.41e-05	0.00027	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.41e-05	0.000269	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.4e-05	0.000268	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.39e-05	0.000266	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—NME1—peripheral nervous system neoplasm	1.38e-05	0.000264	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—BCHE—peripheral nervous system neoplasm	1.38e-05	0.000263	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PPP3R1—peripheral nervous system neoplasm	1.36e-05	0.000259	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.36e-05	0.000259	CbGpPWpGaD
Dexamethasone—NOS2—Hemostasis—AKT1—peripheral nervous system neoplasm	1.34e-05	0.000256	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.34e-05	0.000255	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.33e-05	0.000255	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—COX2—peripheral nervous system neoplasm	1.33e-05	0.000254	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.33e-05	0.000254	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.32e-05	0.000253	CbGpPWpGaD
Dexamethasone—NOS2—Disease—ERBB2—peripheral nervous system neoplasm	1.32e-05	0.000252	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.31e-05	0.000251	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—TH—peripheral nervous system neoplasm	1.29e-05	0.000248	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ENO2—peripheral nervous system neoplasm	1.29e-05	0.000247	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.28e-05	0.000245	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.27e-05	0.000242	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—GNAS—peripheral nervous system neoplasm	1.27e-05	0.000242	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.24e-05	0.000238	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—ABCB1—peripheral nervous system neoplasm	1.24e-05	0.000238	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.24e-05	0.000236	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.22e-05	0.000234	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.22e-05	0.000233	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.22e-05	0.000233	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.21e-05	0.000232	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.2e-05	0.00023	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.2e-05	0.000229	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—MYC—peripheral nervous system neoplasm	1.2e-05	0.000229	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.19e-05	0.000227	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.18e-05	0.000226	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ENO2—peripheral nervous system neoplasm	1.17e-05	0.000225	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.17e-05	0.000224	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—TH—peripheral nervous system neoplasm	1.17e-05	0.000224	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	1.15e-05	0.00022	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.15e-05	0.00022	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.14e-05	0.000219	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.13e-05	0.000216	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—TH—peripheral nervous system neoplasm	1.13e-05	0.000215	CbGpPWpGaD
Dexamethasone—ANXA1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	1.12e-05	0.000214	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	1.11e-05	0.000212	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.1e-05	0.000211	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.1e-05	0.00021	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—BCHE—peripheral nervous system neoplasm	1.09e-05	0.000208	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.09e-05	0.000208	CbGpPWpGaD
Dexamethasone—NR0B1—Gene Expression—AKT1—peripheral nervous system neoplasm	1.09e-05	0.000208	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.08e-05	0.000207	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.08e-05	0.000207	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.07e-05	0.000206	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.06e-05	0.000203	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—GNAS—peripheral nervous system neoplasm	1.06e-05	0.000202	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.04e-05	0.000199	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.04e-05	0.000199	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	1.04e-05	0.000198	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.03e-05	0.000197	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.03e-05	0.000197	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	0.000196	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	1.02e-05	0.000195	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.02e-05	0.000194	CbGpPWpGaD
Dexamethasone—NOS2—Disease—NRAS—peripheral nervous system neoplasm	1e-05	0.000192	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1e-05	0.000191	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	9.92e-06	0.00019	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	9.9e-06	0.000189	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ENO2—peripheral nervous system neoplasm	9.83e-06	0.000188	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.81e-06	0.000188	CbGpPWpGaD
Dexamethasone—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	9.65e-06	0.000185	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—GNAS—peripheral nervous system neoplasm	9.55e-06	0.000183	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—SLC2A1—peripheral nervous system neoplasm	9.47e-06	0.000181	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	9.46e-06	0.000181	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	9.45e-06	0.000181	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.44e-06	0.000181	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.37e-06	0.000179	CbGpPWpGaD
Dexamethasone—NOS2—Disease—MYC—peripheral nervous system neoplasm	9.33e-06	0.000179	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	9.31e-06	0.000178	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	9.3e-06	0.000178	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ENO2—peripheral nervous system neoplasm	9.26e-06	0.000177	CbGpPWpGaD
Dexamethasone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.26e-06	0.000177	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	9.24e-06	0.000177	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—GNAS—peripheral nervous system neoplasm	9.19e-06	0.000176	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	9.02e-06	0.000173	CbGpPWpGaD
Dexamethasone—NR3C1—Generic Transcription Pathway—MYC—peripheral nervous system neoplasm	8.75e-06	0.000167	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ENO2—peripheral nervous system neoplasm	8.73e-06	0.000167	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—MYC—peripheral nervous system neoplasm	8.67e-06	0.000166	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	8.46e-06	0.000162	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—GNAS—peripheral nervous system neoplasm	8.36e-06	0.00016	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—BCHE—peripheral nervous system neoplasm	8.31e-06	0.000159	CbGpPWpGaD
Dexamethasone—NR3C2—Gene Expression—AKT1—peripheral nervous system neoplasm	8.3e-06	0.000159	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	8.29e-06	0.000159	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—ABCB1—peripheral nervous system neoplasm	8.21e-06	0.000157	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	8.13e-06	0.000156	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	8e-06	0.000153	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	7.99e-06	0.000153	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.93e-06	0.000152	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—BCHE—peripheral nervous system neoplasm	7.82e-06	0.00015	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—TH—peripheral nervous system neoplasm	7.81e-06	0.000149	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	7.81e-06	0.000149	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	7.77e-06	0.000149	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.62e-06	0.000146	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	7.6e-06	0.000145	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	7.51e-06	0.000144	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.46e-06	0.000143	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	7.46e-06	0.000143	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.45e-06	0.000142	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—BCHE—peripheral nervous system neoplasm	7.37e-06	0.000141	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—TH—peripheral nervous system neoplasm	7.35e-06	0.000141	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	7.34e-06	0.00014	CbGpPWpGaD
Dexamethasone—NOS2—Disease—HRAS—peripheral nervous system neoplasm	7.33e-06	0.00014	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—MYC—peripheral nervous system neoplasm	7.29e-06	0.000139	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	7.14e-06	0.000137	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—TP53—peripheral nervous system neoplasm	7.12e-06	0.000136	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	7.09e-06	0.000136	CbGpPWpGaD
Dexamethasone—PLA2G1B—Metabolism—AKT1—peripheral nervous system neoplasm	7.06e-06	0.000135	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.04e-06	0.000135	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	6.97e-06	0.000133	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—TH—peripheral nervous system neoplasm	6.93e-06	0.000133	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	6.81e-06	0.00013	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	6.8e-06	0.00013	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	6.76e-06	0.000129	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.69e-06	0.000128	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	6.57e-06	0.000126	CbGpPWpGaD
Dexamethasone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	6.56e-06	0.000126	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	6.54e-06	0.000125	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	6.51e-06	0.000125	CbGpPWpGaD
Dexamethasone—NOS2—Disease—AKT1—peripheral nervous system neoplasm	6.47e-06	0.000124	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.45e-06	0.000123	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—GNAS—peripheral nervous system neoplasm	6.38e-06	0.000122	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	6.36e-06	0.000122	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.26e-06	0.00012	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	6.13e-06	0.000117	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	6.07e-06	0.000116	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	6.03e-06	0.000115	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.02e-06	0.000115	CbGpPWpGaD
Dexamethasone—ANXA1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	6.01e-06	0.000115	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—GNAS—peripheral nervous system neoplasm	6e-06	0.000115	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	5.99e-06	0.000115	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.89e-06	0.000113	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	5.89e-06	0.000113	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	5.88e-06	0.000112	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.76e-06	0.00011	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	5.67e-06	0.000109	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—GNAS—peripheral nervous system neoplasm	5.66e-06	0.000108	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.62e-06	0.000108	CbGpPWpGaD
Dexamethasone—CYP3A43—Metabolism—AKT1—peripheral nervous system neoplasm	5.55e-06	0.000106	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	5.55e-06	0.000106	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	5.55e-06	0.000106	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	5.54e-06	0.000106	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	5.5e-06	0.000105	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.3e-06	0.000101	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—PTPN11—peripheral nervous system neoplasm	5.29e-06	0.000101	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.25e-06	0.0001	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	5.22e-06	9.99e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	5.19e-06	9.93e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	5.17e-06	9.9e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	5.09e-06	9.74e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	5.09e-06	9.73e-05	CbGpPWpGaD
Dexamethasone—PGR—Gene Expression—AKT1—peripheral nervous system neoplasm	5.05e-06	9.67e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.74e-06	9.07e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	4.63e-06	8.86e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	4.55e-06	8.7e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	4.52e-06	8.65e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	4.3e-06	8.22e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	4.26e-06	8.15e-05	CbGpPWpGaD
Dexamethasone—CYP17A1—Metabolism—AKT1—peripheral nervous system neoplasm	4.25e-06	8.14e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	4.22e-06	8.08e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—MYC—peripheral nervous system neoplasm	4.21e-06	8.06e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—ERBB2—peripheral nervous system neoplasm	4.18e-06	8e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	4.18e-06	8e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	4.14e-06	7.93e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.89e-06	7.45e-05	CbGpPWpGaD
Dexamethasone—CYP11A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.89e-06	7.44e-05	CbGpPWpGaD
Dexamethasone—CYP4A11—Metabolism—AKT1—peripheral nervous system neoplasm	3.85e-06	7.37e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.72e-06	7.12e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	3.63e-06	6.94e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.46e-06	6.62e-05	CbGpPWpGaD
Dexamethasone—ABCB11—Metabolism—AKT1—peripheral nervous system neoplasm	3.41e-06	6.53e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	3.41e-06	6.53e-05	CbGpPWpGaD
Dexamethasone—PGR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	3.29e-06	6.29e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—NRAS—peripheral nervous system neoplasm	3.18e-06	6.09e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—MYC—peripheral nervous system neoplasm	2.96e-06	5.67e-05	CbGpPWpGaD
Dexamethasone—NR3C1—Gene Expression—AKT1—peripheral nervous system neoplasm	2.92e-06	5.59e-05	CbGpPWpGaD
Dexamethasone—SLCO1A2—Metabolism—AKT1—peripheral nervous system neoplasm	2.85e-06	5.45e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	2.79e-06	5.33e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	2.73e-06	5.23e-05	CbGpPWpGaD
Dexamethasone—CYP19A1—Metabolism—AKT1—peripheral nervous system neoplasm	2.58e-06	4.93e-05	CbGpPWpGaD
Dexamethasone—CYP1B1—Metabolism—AKT1—peripheral nervous system neoplasm	2.48e-06	4.75e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—HRAS—peripheral nervous system neoplasm	2.33e-06	4.45e-05	CbGpPWpGaD
Dexamethasone—ABCG2—Metabolism—AKT1—peripheral nervous system neoplasm	2.26e-06	4.32e-05	CbGpPWpGaD
Dexamethasone—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	2.24e-06	4.28e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Disease—AKT1—peripheral nervous system neoplasm	2.06e-06	3.93e-05	CbGpPWpGaD
Dexamethasone—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	2.05e-06	3.92e-05	CbGpPWpGaD
Dexamethasone—PTGS2—Metabolism—AKT1—peripheral nervous system neoplasm	1.72e-06	3.29e-05	CbGpPWpGaD
Dexamethasone—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	1.65e-06	3.17e-05	CbGpPWpGaD
Dexamethasone—CYP2E1—Metabolism—AKT1—peripheral nervous system neoplasm	1.62e-06	3.1e-05	CbGpPWpGaD
Dexamethasone—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	1.62e-06	3.09e-05	CbGpPWpGaD
Dexamethasone—CYP1A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.53e-06	2.92e-05	CbGpPWpGaD
Dexamethasone—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.4e-06	2.68e-05	CbGpPWpGaD
Dexamethasone—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.25e-06	2.39e-05	CbGpPWpGaD
Dexamethasone—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.22e-06	2.33e-05	CbGpPWpGaD
Dexamethasone—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.15e-06	2.2e-05	CbGpPWpGaD
Dexamethasone—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.14e-06	2.18e-05	CbGpPWpGaD
Dexamethasone—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	7.52e-07	1.44e-05	CbGpPWpGaD
